CARDIOVASCULAR
ENGINEERING
Journal for Extracorporeal Circulation, Assist Devices,Transplantation and Artificial Organs

Volume 5, 2000, No 4



Long-term Survivors (Longer than 5 Years) after Pediatric Heart Transplantation with Reduced Immunosuppression Therapy
K. Minami, Y. Bonkohara, E. zu Knyphausen, G. Tenderich, U. Blanz, T. Breymann, N. Reiß, D. Böthig, H. Meyer, R. Körfer

Background:  Pediatric heart transplantation has recently become an accepted method of treatment for end-stage pediatric heart disease.  However, the long-term result is still an interesting issue, especially in point of allograft function, complications of immunosuppression, and quality of life in long-term survivors.
Methods:  From March 1989 through 1999, 83 patients (< 16 years) underwent heart transplantation in our institute.  Of these patients, we focused on 33 patients who have survived more than 5 years from transplantation and examined shortening fraction of the left ventricle, left ventricular enddiastolic pressure by echocardiography, coronary angiogram, complications of immunosuppression, and their daily lives.
Results:  The 1-, 3-, 5-year actuarial survival rates were 81%, 78%, and 74% respectively.  The function of the left ventricle was normal in most patients, however, 16% of them had mild narrowing or other abnormalities of coronary arteries.  Eighty-one percent of long-term survivors were steroid-free, 31% with cyclosporine monotherapy, and 44% with cyclosporine and azathioprine double drug therapy.
Nephrotoxicity was the most common complication of immunosuppression, however, none of them had critical renal dysfunction.  Almost all patients are doing age appropriate activities. 
Conclusion:  The long-term results of pediatric heart transplantation are satisfactory.  However, renal dysfunction  caused by immunosuppression can be aggravated after 10 years from heart transplantation. 

(CVE. 2000; 5 (4): 248-252)

Key words:  pediatric heart transplantation, long-term survivor, allograft function, posttransplant coronary artery disease, immunosuppression, quality of life

Kazutomo Minami, M.D., Ph.D.
Herzzentrum NRW
Klinik für Thorax- und Kardiovaskularchirurgie
Georgstr.11
D-32545 Bad Oeynhausen
Germany
E-mail: kminami@mailman.hdz-nrw.ruhr-uni-bochum.de



PSP-Logo
PABST SCIENCE PUBLISHERS
Lengerich, Berlin, Riga, Rom, Wien, Zagreb